BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10749330)

  • 21. Chronic oral administration of protease inhibitor decreases CCK-A receptor mRNA expression but increases pancreatic growth in rats.
    Fukumitsu K; Nakamura H; Otsuki M
    Pancreas; 2001 Mar; 22(2):179-85. PubMed ID: 11249073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient agonist-induced regulation of the cholecystokinin-A and cholecystokinin-B receptor mRNA levels in rat pancreatic acinar AR42J cells.
    Günther R; Carstens OC; Schmidt WE; Fölsch UR
    Pancreatology; 2003; 3(1):47-54. PubMed ID: 12649564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
    Zhou W; Povoski SP; Longnecker DS; Bell RH
    Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cholecystokinin, gastrin, CCK-A receptor, and CCK-B/gastrin receptor gene expressions in gastric cancer.
    Okada N; Kubota A; Imamura T; Suwa H; Kawaguchi Y; Ohshio G; Seino Y; Imamura M
    Cancer Lett; 1996 Sep; 106(2):257-62. PubMed ID: 8844981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pig pancreatic acinar cells possess predominantly the CCK-B receptor subtype.
    Morisset J; Levenez F; Corring T; Benrezzak O; Pelletier G; Calvo E
    Am J Physiol; 1996 Aug; 271(2 Pt 1):E397-402. PubMed ID: 8770035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal, and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents.
    Schaer JC; Reubi JC
    J Clin Endocrinol Metab; 1999 Jan; 84(1):233-9. PubMed ID: 9920090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of gastrin mRNA and peptide in normal and cancerous human pancreas.
    Smith JP; Hamory MW; Verderame MF; Zagon IS
    Int J Mol Med; 1998 Sep; 2(3):309-15. PubMed ID: 9855703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice.
    Smith JP; Cooper TK; McGovern CO; Gilius EL; Zhong Q; Liao J; Molinolo AA; Gutkind JS; Matters GL
    Pancreas; 2014 Oct; 43(7):1050-9. PubMed ID: 25058882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical examination of cholecystokinin and gastrin receptors (CCK-2/gastrin-R) expression in normal and exocrine cancerous human pancreatic tissues.
    Sellam F; Harir N; Khaled MB; Mrabent NM; Belkralladi H; Tou A; Diaf M; Salah R; Moulessehoul S
    Pancreatology; 2015; 15(6):661-6. PubMed ID: 26520651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of phospholipase C by cholecystokinin receptor subtypes with different G-protein-coupling specificities in hormone-secreting pancreatic cell lines.
    Paulssen RH; Fraeyman N; Florholmen J
    Biochem Pharmacol; 2000 Sep; 60(6):865-75. PubMed ID: 10930542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron.
    Ding WQ; Kuntz SM; Miller LJ
    Cancer Res; 2002 Feb; 62(3):947-52. PubMed ID: 11830556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular calcium sensing receptor in human pancreatic cells.
    Rácz GZ; Kittel A; Riccardi D; Case RM; Elliott AC; Varga G
    Gut; 2002 Nov; 51(5):705-11. PubMed ID: 12377811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecystokinin receptors in human pancreatic cancer cell lines.
    Mandair KK; Towner P; Stamford IF; Morris JD; Harper E; Benjamin IS; Tavares IA
    Eur J Cancer; 1998 Aug; 34(9):1455-9. PubMed ID: 9849431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin.
    Ji B; Bi Y; Simeone D; Mortensen RM; Logsdon CD
    Gastroenterology; 2001 Dec; 121(6):1380-90. PubMed ID: 11729117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas.
    Rooman I; Lardon J; Flamez D; Schuit F; Bouwens L
    Gastroenterology; 2001 Oct; 121(4):940-9. PubMed ID: 11606507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of cholecystokinin release and transcription in a rat without gene expression of cholecystokinin-A receptor.
    Miyasaka K; Masuda M; Funakoshi A
    Digestion; 1997; 58(2):104-10. PubMed ID: 9144298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of target cells for cholecystokinin in the porcine pancreas.
    Schweiger M; Steffl M; Amselgruber WM
    Ann Anat; 2005 Jul; 187(3):209-14. PubMed ID: 16130820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia.
    Broberger C; Holmberg K; Shi TJ; Dockray G; Hökfelt T
    Brain Res; 2001 Jun; 903(1-2):128-40. PubMed ID: 11382396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines.
    Biagini P; Monges G; Vuaroqueaux V; Parriaux D; Cantaloube JF; De Micco P
    Life Sci; 1997; 61(10):1009-18. PubMed ID: 9296339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cholecystokinin-B/gastrin receptors in medullary thyroid cancer.
    Amiri-Mosavi A; Ahlman H; Tisell LE; Wängberg B; Kölby L; Forssell-Aronsson E; Lundberg PA; Lindstedt G; Nilsson O
    Eur J Surg; 1999 Jul; 165(7):628-31. PubMed ID: 10452255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.